학술논문

Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®
Document Type
Short Communication
Source
In Bioorganic & Medicinal Chemistry Letters 15 August 2019 29(16):2415-2427
Subject
Language
ISSN
0960-894X